HUMANA INC HUM

Financials SIC 6324 - Hospital & Medical Service Plans NAICS Finance and Insurance › Insurance Carriers and Related Activities › Insurance Carriers derived NYSE

Last close 422.07 2026-10-23
Market cap $50.67B 2026-03-31 share count
52-week range 163.11 - 456.50

Valuation FY2025 figures against the last close

P/S8.7x
P/E42.9x
P/FCF135.1x
EV/EBITDA12.4x
Dividend yield0.8%
Diluted EPS9.84

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.83B$4.43B$4.03B$4.78B$3.06B$1.81B$1.44B$1.46B$982.0M$969.0M
SG&A $15.45B$13.70B$13.19B$12.67B$10.12B$10.05B$7.38B$7.53B$6.57B$7.17B
Operating income $2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B
Interest expense $631.0M$660.0M$493.0M$401.0M$326.0M$283.0M$242.0M$218.0M$242.0M$189.0M
Pre-tax income $1.44B$1.62B$3.33B$3.57B$3.42B$4.67B$3.47B$2.07B$4.02B$1.55B
Income tax $250.0M$413.0M$836.0M$762.0M$485.0M$1.31B$763.0M$391.0M$1.57B$938.0M
Net income $1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614.0M
EPS, basic 9.8710.0120.0922.2022.7925.4720.2012.2416.944.11
EPS, diluted 9.849.9820.0022.0822.6725.3120.1012.1616.814.07
Shares, diluted (wtd. avg.) 120.8M120.9M124.4M127.1M129.4M133.0M134.7M138.4M145.6M150.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $4.20B$2.22B$4.69B$5.06B$3.39B$4.67B$4.05B$2.34B$4.04B$3.88B
Short-term investments $15.70B$18.21B$16.63B$13.88B$13.19B$12.55B$10.97B$10.03B$9.56B$7.59B
Receivables $3.27B$2.70B$2.04B$1.67B$1.81B$1.14B$1.06B$1.01B$854.0M$1.28B
Total current assets $32.73B$29.82B$29.99B$26.18B$24.89B$23.64B$19.89B$16.95B$17.40B$16.19B
Property, plant and equipment $2.23B$2.53B$3.03B$3.22B$3.07B$2.37B$1.96B$1.74B$1.58B$1.50B
Goodwill $9.69B$9.63B$9.55B$9.14B$11.09B$4.45B$3.93B$3.90B$3.28B$3.27B
Other intangibles $1.13B$1.44B$1.69B$1.76B$2.64B$329.0M$177.0M$245.0M$226.0M$280.0M
Total assets $48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B
Accounts payable $5.72B$5.26B$6.57B$5.24B$4.51B$4.01B$3.75B$3.07B$4.07B$2.47B
Short-term debt $0$577.0M$1.44B$2.09B$1.95B$600.0M$699.0M$1.69B$150.0M$300.0M
Total current liabilities $16.35B$16.94B$18.87B$17.18B$15.33B$13.39B$10.93B$10.08B$9.41B$7.82B
Long-term debt $12.37B$11.14B$10.21B$9.03B$10.54B$6.06B$4.97B$4.38B$4.77B$3.79B
Total liabilities $31.17B$30.03B$30.75B$27.68B$28.25B$21.24B$17.04B$15.25B$17.34B$14.71B
Retained earnings $29.07B$28.32B$27.54B$25.49B$23.09B$20.52B$17.48B$15.07B$13.67B$11.45B
Total equity $17.66B$16.38B$16.32B$15.37B$16.10B$13.73B$12.04B$10.16B$9.84B$10.69B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $921.0M$2.97B$3.98B$4.59B$2.26B$5.64B$5.28B$2.17B$4.05B$1.94B
Depreciation and amortisation $773.0M$908.0M$850.0M$749.0M$640.0M$528.0M$505.0M$444.0M$410.0M$388.0M
Stock-based compensation $241.0M$207.0M$175.0M$216.0M$180.0M$181.0M$163.0M$137.0M$157.0M$115.0M
Capital expenditure $546.0M$575.0M$1.00B$1.14B$1.34B$964.0M$736.0M$612.0M$524.0M$527.0M
Investing cash flow $2.27B-$2.95B-$3.49B-$1.01B-$6.56B-$3.06B-$1.28B-$3.09B-$2.94B-$1.36B
Financing cash flow -$1.22B-$2.49B-$856.0M-$1.91B$3.02B-$1.96B-$2.29B-$785.0M-$945.0M$732.0M
Dividends paid $430.0M$431.0M$431.0M$392.0M$354.0M$323.0M$291.0M$265.0M$220.0M$177.0M
Buybacks $151.0M$817.0M$1.57B$2.10B$79.0M$1.82B$1.07B$1.09B$3.37B$104.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000049071-26-000009.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2B 4B 6B Revenue, FY2016: 969M Net income, FY2016: 614M Revenue, FY2017: 982M Net income, FY2017: 2.4B Revenue, FY2018: 1.5B Net income, FY2018: 1.7B Revenue, FY2019: 1.4B Net income, FY2019: 2.7B Revenue, FY2020: 1.8B Net income, FY2020: 3.4B Revenue, FY2021: 3.1B Net income, FY2021: 2.9B Revenue, FY2022: 4.8B Net income, FY2022: 2.8B Revenue, FY2023: 4B Net income, FY2023: 2.5B Revenue, FY2024: 4.4B Net income, FY2024: 1.2B Revenue, FY2025: 5.8B Net income, FY2025: 1.2B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $969.0M $982.0M $1.46B $1.44B $1.81B $3.06B $4.78B $4.03B $4.43B $5.83B
Gross profit — — — — — — — — — —
Net income $614.0M $2.45B $1.68B $2.71B $3.37B $2.93B $2.81B $2.49B $1.21B $1.19B

Recent filings and events

  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Item 5.02
  • Material agreement signed Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6324

TickerCompanyMarket capP/ERevenue growth
UNH UNITEDHEALTH GROUP INC $375.28B 31.6x 11.8%
ELV Elevance Health, Inc. $95.41B 17.5x 12.5%
CI Cigna Group $81.11B 13.8x 11.2%
CNC CENTENE CORP $34.66B — 20.0%
MOH MOLINA HEALTHCARE, INC. $10.92B 23.4x 11.7%
OSCR Oscar Health, Inc. $9.37B — 39.0%
CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE $2.41B — 40.3%
ALHC Alignment Healthcare, Inc. $1.67B — 46.1%